ニキビ治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Acne Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Acne: An overview
Understanding the disease
Pathophysiology
Causes
Types of acne
Implications of acne
Management
Epidemiology

PART 06: Pipeline analysis
Sarecycline
IDP-121
CB-03-01
IDP-120
CB-06-04
ASC-J9
Visonac
DRM-01
FMX101
True human antibody RA-18C3
SB204
Acebilustat
ANT-1207

PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 08: Reimbursement scenario for acne drugs

PART 09: Market segmentation by drug class
Antibiotics
Anti-inflammatory drugs
Antimicrobials
Combination drugs
Hormonal agents
Oral retinoids
Topical retinoids

PART 10: Market segmentation by route of administration
Topical
Oral

PART 11: Market segmentation by type
Prescription drugs
OTC drugs

PART 12: Global acne drugs market: OTC drugs
Major acne OTC products
Adverse effects of OTC acne drugs
Major vendors of OTC acne drugs
OTC acne drugs market in Europe

PART 13: Geographical segmentation
Acne drugs market in Americas
Global acne drugs market in EMEA
Acne drugs market in APAC

PART 14: Market drivers
Prevalence of acne
Lifestyle changes
Significant unmet medical needs
Promising drug pipeline
Rise in disposable income

PART 15: Impact of drivers

PART 16: Market challenges
Adverse effects of drugs
Poor patient adherence
Preference for alternative therapies
Intense market competition

PART 17: Impact of drivers and challenges

PART 18: Market trends
Preference for combination therapies
Acne awareness programs
Product innovations
Increased use of OTC products over prescription drugs
Marketing of OTC acne products

PART 19: Vendor landscape
Competitive scenario
Market share analysis 2015
Valeant Pharmaceuticals
Galderma
Allergan
Stiefel Laboratories
Other prominent vendors

PART 20: Appendix
List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Acne drugs: Key buying criteria
Exhibit 03: Types of acne based on severity
Exhibit 04: Types of acne based on severity of inflammation
Exhibit 05: Implications of acne
Exhibit 06: Treatment algorithm: Management of acne
Exhibit 07: Acne drugs: Pipeline portfolio
Exhibit 08: Global acne drugs market 2015-2020 ($ millions)
Exhibit 09: Five forces analysis
Exhibit 10: Oral prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 11: Topical prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 12: Global acne drugs market segmentation by drug class
Exhibit 13: Global acne drugs market segmentation by route of administration
Exhibit 14: Global acne drugs market segmentation by route of administration 2015
Exhibit 15: Revenue of topical prescription drugs in US 2015
Exhibit 16: Revenue of oral prescription drugs in US 2015
Exhibit 17: Global acne drugs market segmentation by type
Exhibit 18: Global acne drugs market segmentation by type 2015
Exhibit 19: OTC drugs: Advantages and disadvantages
Exhibit 20: AcneFree by Valeant Pharmaceuticals: SWOT analysis
Exhibit 21: Clearasil by Reckitt Benckiser: SWOT analysis
Exhibit 22: Clean & Clear by Johnson & Johnson: SWOT analysis
Exhibit 23: Neutrogena by Johnson & Johnson: SWOT analysis
Exhibit 24: Proactiv by Guthy-Renker: SWOT analysis
Exhibit 25: Global acne drugs market segmentation by geography 2015
Exhibit 26: Global acne drugs market segmentation by geography 2015-2020 ($ millions)
Exhibit 27: Acne drugs market in Americas 2015-2020 ($ millions)
Exhibit 28: Acne drugs market in US 2015-2020 ($ millions)
Exhibit 29: Acne drugs market in EMEA 2015-2020 ($ millions)
Exhibit 30: Acne drugs market in APAC 2015-2020 ($ millions)
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: Ranking of leading vendors 2015
Exhibit 34: Valeant Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 35: Valeant Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Valeant Pharmaceuticals: Product segmentation by revenue 2014
Exhibit 37: Valeant Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 38: Valeant Pharmaceuticals: SWOT analysis
Exhibit 39: Galderma: Therapeutic categories
Exhibit 40: Galderma: SWOT analysis
Exhibit 41: Allergan: Business segmentation by product revenue 2014
Exhibit 42: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 43: Allergan: Geographical segmentation by revenue 2014
Exhibit 44: Allergan: SWOT analysis
Exhibit 45: Stiefel Laboratories: Product categories
Exhibit 46: Stiefel Laboratories: SWOT analysis


【レポート販売概要】

■ タイトル:ニキビ治療薬の世界市場2016-2020
■ 英文:Global Acne Drugs Market 2016-2020
■ 発行日:2015年11月18日
■ 調査会社:Technavio
■ 商品コード:
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。